Silva A Sofia, Sousa Ana M, Cabral Renato P, Silva Marta C, Costa Clarinda, Miguel Sónia P, Bonifácio Vasco D B, Casimiro Teresa, Correia Ilídio J, Aguiar-Ricardo Ana
LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal; CICS-UBI, Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Avenida Infante D. Henrique, 6200-506 Covilhã, Portugal.
LAQV-REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal.
Int J Pharm. 2017 Mar 15;519(1-2):240-249. doi: 10.1016/j.ijpharm.2017.01.032. Epub 2017 Jan 19.
Functionalized gold nanoparticles (AuNPs) have been widely investigated as promising multifunctional nanosystems for the theragnosis of lung cancer, the most common and prominent cause of cancer death worldwide. Nevertheless, nanoparticles are not in appropriate sizes for an accurate deep lung delivery and the lack of locally and effective delivery of therapeutic biomolecules to the deep lungs is, in fact, the major cause of low therapeutic outcome. Herein we incorporate, for the first time, AuNPs into respirable microparticles. AuNPs were functionalized with biocompatible oligo(2-oxazoline)-based optically stable fluorescent coatings, and conjugated with a laminin peptide (YIGSR) for targeted lung cancer delivery. These POxylated AuNPs were then incorporated into a chitosan matrix by a clean process, supercritical CO-assisted spray drying (SASD), yielding nano-in-micro clean ultrafine dry powder formulations. The engineered formulations present the adequate morphology and flowability to reach the deep lung, with aerodynamic sizes ranging 3.2-3.8μm, and excellent fine particle fraction (FPF) (FPF of 47% for CHT-bearing targeted AuNPs). The optimal biodegradation and release profiles enabled a sustained and controlled release of the embedded nanoparticles, with enhanced cellular uptake, opening new prospects for future lung theragnosis.
功能化金纳米颗粒(AuNPs)作为用于肺癌诊疗的多功能纳米系统已被广泛研究,肺癌是全球癌症死亡最常见且突出的原因。然而,纳米颗粒尺寸并不适合准确地深入肺部递送,而治疗性生物分子缺乏向深部肺部的局部有效递送实际上是治疗效果不佳的主要原因。在此,我们首次将AuNPs纳入可吸入微粒中。AuNPs用基于生物相容性聚(2-恶唑啉)的光学稳定荧光涂层进行功能化,并与层粘连蛋白肽(YIGSR)偶联以实现靶向肺癌递送。然后通过超临界CO₂辅助喷雾干燥(SASD)这一清洁工艺将这些聚氧化乙烯化的AuNPs纳入壳聚糖基质中,得到纳米包埋型清洁超细干粉制剂。所设计的制剂呈现出足以抵达深部肺部的形态和流动性,空气动力学尺寸范围为3.2 - 3.8μm,并且具有优异的细颗粒分数(FPF)(含壳聚糖的靶向AuNPs的FPF为47%);最佳的生物降解和释放特性能够实现包埋纳米颗粒的持续和控释,增强细胞摄取,为未来肺部诊疗开辟了新前景。